| HL (n = 295) | LL (n = 221) | P value |
---|---|---|---|
Sex [n (%)] | Â | Â | 0.732 |
 Male | 196 (66.4) | 150 (67.9) |  |
 Female | 99 (33.6) | 71 (32.1) |  |
Age: years | 63.3 ± 10.7 | 64.4 ± 9.8 | 0.471 |
BMI: kg/m2 | 22.3 ± 3.0 | 22.4 ± 3.1 | 0.832 |
ASA classification | Â | Â | 0.117 |
 I | 151 (51.2) | 97 (43.9) |  |
 II | 101 (34.2) | 78 (35.3) |  |
 III | 43 (14.6) | 46 (20.8) |  |
Preoperative Hb: g/L | 129.7 ± 11.4 | 131.6 ± 10.7 | 0.285 |
Preoperative Alb: g/L | 34.8 ± 3.4 | 35.0 ± 3.5 | 0.657 |
Tumor location [n (%)] | Â | Â | 0.459 |
 Upper rectum a | 77 (26.1) | 66 (29.9) |  |
 Middle rectum b | 133 (45.1) | 101 (45.7) |  |
 Lower rectum c | 85 (28.8) | 54 (24.4) |  |
Neoadjuvant therapy d [n (%)] | 65 (22.0) | 46 (20.8) | 0.739 |
Postoperative adjuvant treatment [n (%)] | 89 (30.2) | 71 (32.1) | 0.634 |